There an ongoing controversy regarding the possible causal link between the use of cannabis and the onset of schizophrenia. Data from clinical research has offer mixed, inconsistent results.
Researchers from a range of impressive educational and medical institutions. The institutions involved were the Feinstein Institute for medical research, the Zucker Hillside Hospital in New York, the Albert Einstein College of Medicine and Princeton University. Selected researchers compared neurocognition in 175 patients with schizophrenia with a history of cannabis use. They also studied 280 subjects without a history of cannabis use.
Cannabis users had better overall Global Assessment of Functioning (GAF) scores. In the study, cannabis users performed better in the following areas:
There is no concrete evidence that assures marijuana can cause schizophrenia. Though it is common for schizophrenic patients to use marijuana, it cannot be confirmed if the correlation is due to self-medication or the cause of illness. In fact, there is evidence asserting medical marijuana may ease symptoms of schizophrenia. Selective cannabinoids may ease anxiety, paranoia, hallucinations, and psychosis–all symptoms of schizophrenia.
These findings suggest schizophrenic patients, with a comorbid cannabis use disorder, may represent a high functioning subgroup of schizophrenic patients. If you are interested in using cannabis to treat schizophrenia or other ailments, you must first consult your doctor. It is required, as you’ll need a doctor’s prescription. They’re also the most qualified to give you individualized treatment advice.
As medical cannabis is still illegal in most of the world and many states, you must check your federal or state laws accordingly to avoid partaking in illegal activity. Schizophrenia is part of a list of mood disorders that have the potential to be treated with cannabinoids.